Pay in 4 interest-free payments of $6.22 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Here are actionable tips to ensure each session is stress-free and effective: Get proper instruction: Ask your healthcare provider for a live demo or video tutorial
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Any retatrutide currently in circulation outside of formal clinical trials is typically supplied as a research-grade lyophilised (freeze-dried) powder, intended strictly for laboratory or research purposes
Both are administered by licensed NPs and RNs via intramuscular injection for near-100% absorption, bypassing the digestive system entirely
